Carregant...

Expression of SART3 Tumor‐rejection Antigen in Gastric Cancers

We previously reported SART3 as a tumor‐rejection antigen recognized by histocompatibility leukocyte antigen (HLA)‐A24‐restricted cytotoxic T lymphocytes (CTLs). In this study, we investigated the expression of the SART3 antigen in gastric cancers, as a candidate for use in specific immunotherapy. T...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Jpn J Cancer Res
Autors principals: Niiya, Fumihiko, Nishizaka, Shinya, Matsunaga, Kazuko, Koufuji, Kikuo, Mori, Masaki, Katai, Hitoshi, Yamana, Hideaki, Itoh, Kyogo
Format: Artigo
Idioma:Inglês
Publicat: Blackwell Publishing Ltd 2000
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5926363/
https://ncbi.nlm.nih.gov/pubmed/10760694
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1349-7006.2000.tb00950.x
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!